Home
Conditions
Liver Diseases

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,353 public trials 1,303 recruiting studies

Refine in advanced search Browse all conditions

Liver Diseases trial results

Not Yet Recruiting

Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Tolerant Chronic Hepatitis B

NCT07345624

Conditions: Blood-Borne Infections, Bronchial Diseases, Bronchiolitis, +28 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study of the Pharmacokinetics and Safety of Anaprazole Sodium in Special Populations

NCT07345689

Conditions: Digestive System Diseases, Elderly, Female Urogenital Diseases, +8 more
Locations: The First Bethune Hospital of Jilin University Changchun, Jilin, China

View Trial Details

Not Yet Recruiting

Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Active Chronic Hepatitis B

NCT07345611

Conditions: Blood-Borne Infections, Bronchial Diseases, Bronchiolitis, +28 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

ENDOCARE-SCREEN: Metabolic Liver Dysfunction Screening Study

NCT07336563

Conditions: Body Weight, Digestive System Diseases, Fatty Liver, +18 more
Locations: ENDOCARE Wroclaw, Poland

View Trial Details

Not Yet Recruiting

SARS-CoV-2 mRNA Vaccination in Patients With Hepatocellular Carcinoma Treated With Immune Checkpoint Inhibitors

NCT07341321

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
Locations: Medical University of Graz Graz, Austria

Ordensklinikum Linz Linz, Austria

University Hospital St. Pölten Sankt Pölten, Austria

Krankenhaus der Barmherzigen Brüder St Veit an der Glan Sankt Veit an der Glan, Austria

View Trial Details

Not Yet Recruiting

the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines

NCT07338851

Conditions: Central Nervous System Diseases, Central Nervous System Infections, Digestive System Diseases, +30 more
Locations: Si County Center for Disease Control and Prevention Suzhou, Anhui, China

Feixiang District Center for Disease Control and Prevention Handan, Hebei, China

Sheyang County Center for Disease Control and Prevention Yancheng, Jiangsu, China

Chenggu County Center for Disease Control and Prevention Hanzhong, Shaanxi, China

View Trial Details

Not Yet Recruiting

Metabolic Changes Associated With Weight Gain After Treatment of Achalasia

NCT07334639

Conditions: Achalasia, Esophageal, Body Weight, Body Weight Changes, +21 more
Locations: Hadassah Medical Center Jerusalem, Israel

Shamir Medical Center Ẕerifin, Israel

View Trial Details

Not Yet Recruiting

A Trial of Behavioral Intervention on Prognostic Survival of Patients With Unresectable Liver Cancer

NCT07337031

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Eastern Hepatobiliary Surgery Hospital Shanghai, China

View Trial Details

Not Yet Recruiting

Long Term Prediction of MASH-related HCC Risk by Proteomics

NCT07332611

Conditions: Carcinoma, Digestive System Diseases, Fatty Liver, +5 more
Locations: CHU Bordeaux Pessac, France

View Trial Details

Not Yet Recruiting

Ivarmacitinib Combined With Camrelizumab and Apatinib for Unresectable Advanced Hepatocellular Carcinoma With Acquired Resistance to Immune Checkpoint Therapy: A Single-Arm Exploratory Clinical Study

NCT07324473

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China

View Trial Details

Liver Diseases

Liver Diseases trial results

Related conditions